Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on March 10, 2025, regarding events occurring on March 5, 2025, and March 10, 2025. Acadia Healthcare Company, Inc. (ACHC) announced and executed a private offering of senior notes to refinance existing credit facilities.
Key Financial Metrics and Transaction Details
- Debt Issuance: $550 million aggregate principal amount of 7.375% Senior Notes due 2033.
- Interest Rate: 7.375% per annum, payable semi-annually starting September 15, 2025.
- Maturity Date: March 15, 2033.
- Use of Proceeds: Prepayment of outstanding borrowings under the Company's existing senior secured revolving line of credit.
- Security Status: Senior unsecured obligations, fully and unconditionally guaranteed by Guarantors.
- Revenue/Profit/Cash Flow: The filing text does not provide a clear value for current period revenue, profit, cash flow, or margins as this is a transactional report, not a periodic financial statement.
Material Changes and Covenants
The issuance of the Notes represents a material change in the Company's capital structure, replacing revolving credit facility debt with long-term fixed-rate debt. The Indenture includes covenants limiting the Company's ability to:
- Incur additional indebtedness.
- Create liens.
- Pay dividends or make distributions on capital stock.
- Purchase or redeem capital stock.
- Make restricted payments or investments.
- Sell assets or enter into affiliate transactions.
Certain covenants regarding dividends, restricted payments, and indebtedness will be suspended if the Notes achieve an investment-grade rating.
Redemption Terms and Risks
Redemption Options:
- After March 15, 2028: Redeemable at specified prices plus accrued interest.
- Before March 15, 2028 (Equity Proceeds): Up to 40% of Notes redeemable at 107.375% of principal plus accrued interest using net cash proceeds from equity offerings.
- Before March 15, 2028 (Make-Whole): Redeemable at 100% of principal plus accrued interest and an applicable "make-whole" premium.
Risks and Contingencies: The filing highlights risks including difficulties in integrating acquisitions, potential reductions in government/commercial payor rates, patient incidents, litigation, cybersecurity threats, and the risk of insufficient cash flow to service debt. Forward-looking statements are subject to these uncertainties.
Investor Verification Checklist
- Verify the exact amount of the existing senior secured revolving line of credit being prepaid to confirm the net impact on liquidity.
- Review the full text of the Indenture (Exhibit 4.1) for specific definitions of "investment grade" and the mechanics of covenant suspension.
- Confirm the Company's current credit rating to assess the likelihood of covenant suspension.
- Examine the "make-whole" premium calculation in the Indenture to understand early redemption costs.
- Check subsequent filings for any updates on the integration of acquired facilities or changes in patient volumes mentioned in the risk factors.